Literature DB >> 15474006

The erythrocyte skeletons of beta-adducin deficient mice have altered levels of tropomyosin, tropomodulin and EcapZ.

Fabiola Porro1, Luisa Costessi, Martín L Marro, Francisco E Baralle, Andrés F Muro.   

Abstract

The erythrocyte membrane cytoskeleton is organized as a polygonal spectrin network linked to short actin filaments that are capped by adducin at the barbed ends. We have constructed a mouse strain deficient in beta-adducin having abnormal erythrocytes. We show here that the levels of several skeletal proteins from beta-adducin mutant erythrocytes are altered. In fact, CapZ, the main muscle actin-capping protein of the barbed ends that in the erythrocytes is cytoplasmic, is 9-fold upregulated in mutant skeletons of erythrocytes suggesting a compensatory mechanism. We also detected upregulation of tropomodulin and downregulation of alpha-tropomyosin and actin. In addition, purified adducin can be re-incorporated into adducin-deficient ghosts. Copyright 2004 Federation of European Biochemical Societies

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474006     DOI: 10.1016/j.febslet.2004.08.057

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Analysis of novel sph (spherocytosis) alleles in mice reveals allele-specific loss of band 3 and adducin in alpha-spectrin-deficient red cells.

Authors:  Raymond F Robledo; Amy J Lambert; Connie S Birkenmeier; Marius V Cirlan; Andreea Flavia M Cirlan; Dean R Campagna; Samuel E Lux; Luanne L Peters
Journal:  Blood       Date:  2010-01-07       Impact factor: 22.113

Review 2.  Feisty filaments: actin dynamics in the red blood cell membrane skeleton.

Authors:  David S Gokhin; Velia M Fowler
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

3.  Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of tropomodulin 3 in red blood cells and disruption of the membrane skeleton.

Authors:  Jeannette D Moyer; Roberta B Nowak; Nancy E Kim; Sandra K Larkin; Luanne L Peters; John Hartwig; Frans A Kuypers; Velia M Fowler
Journal:  Blood       Date:  2010-06-28       Impact factor: 22.113

4.  Comparative proteomics reveals deficiency of SLC9A1 (sodium/hydrogen exchanger NHE1) in β-adducin null red cells.

Authors:  Jason M Wooden; Greg L Finney; Eric Rynes; Michael J Maccoss; Amy J Lambert; Raymond F Robledo; Luanne L Peters; Diana M Gilligan
Journal:  Br J Haematol       Date:  2011-06-21       Impact factor: 6.998

5.  Erythrocyte adducin: a structural regulator of the red blood cell membrane.

Authors:  T Franco; P S Low
Journal:  Transfus Clin Biol       Date:  2010-07-23       Impact factor: 1.406

6.  Unexpected rescue of alpha-synuclein and multimerin1 deletion in C57BL/6JOlaHsd mice by beta-adducin knockout.

Authors:  Srećko Gajović; Dinko Mitrecić; Lana Augustincić; Alessandra Iaconcig; Andrés F Muro
Journal:  Transgenic Res       Date:  2006-04       Impact factor: 2.788

7.  Targeted deletion of the gamma-adducin gene (Add3) in mice reveals differences in alpha-adducin interactions in erythroid and nonerythroid cells.

Authors:  Kenneth E Sahr; Amy J Lambert; Steven L Ciciotte; Narla Mohandas; Luanne L Peters
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

8.  Strain-specific hyperkyphosis and megaesophagus in Add1 null mice.

Authors:  Raymond F Robledo; Kevin L Seburn; Anthony Nicholson; Luanne L Peters
Journal:  Genesis       Date:  2012-09-12       Impact factor: 2.487

9.  Targeted deletion of alpha-adducin results in absent beta- and gamma-adducin, compensated hemolytic anemia, and lethal hydrocephalus in mice.

Authors:  Raymond F Robledo; Steven L Ciciotte; Babette Gwynn; Kenneth E Sahr; Diana M Gilligan; Narla Mohandas; Luanne L Peters
Journal:  Blood       Date:  2008-08-22       Impact factor: 22.113

10.  Hematopoietic protein-1 regulates the actin membrane skeleton and membrane stability in murine erythrocytes.

Authors:  Maia M Chan; Jason M Wooden; Mark Tsang; Diana M Gilligan; Dinesh K Hirenallur-S; Greg L Finney; Eric Rynes; Michael Maccoss; Julita A Ramirez; Heon Park; Brian M Iritani
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.